Merck to buy drug developer Pandion Therapeutics for $1.85 bln

Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%. Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

Reuters | Updated: 25-02-2021 18:14 IST | Created: 25-02-2021 18:09 IST
Merck to buy drug developer Pandion Therapeutics for $1.85 bln
Representative image. Image Credit: Wikimedia

Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, expanding its portfolio of drugs that target autoimmune diseases.

The $60-per-share deal represents about 134% premium to Pandion's closing price on Wednesday. Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%.

Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. In November, Merck agreed to buy privately-held VelosBio for $2.75 billion to strengthen its cancer drug portfolio as the drugmaker looks to reduce its reliance on its blockbuster cancer therapy Keytruda.

The deal between Merck and Pandion is expected to close in the first half of 2021, the companies said in a joint statement. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

East African women traders: 'Celebrating the past, planning for the future'

COVID-19 has hit women disproportionately hard across East Africa, especially those working in the informal sector. Lessons must be learnt to prevent this from happening again....

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

Videos

Latest News

Virat Kohli becomes first batsman to complete 6,000 runs in IPL

Royal Challengers Bangalore RCB skipper Virat Kohli on Thursday became the first batsman to complete 6,000 runs in the Indian Premier League IPL. Playing in his 196th IPL match here at the Wankhede Stadium, Kohli achieved the feat in the 13...

PIL in SC to transfer Kerala journalist Siddique Kappan to AIIMS Delhi from Mathura hospital

The Kerala Union of Working Journalists KUWJ on Thursday filed a habeas corpus writ petition before the Supreme Court seeking its immediate direction to transfer journalist Siddique Kappan from Mathura hospital to AIIMS Delhi due to his ser...

Oxygen Express leaves for Maharashtra from RINL plant

State-run RINL on Thursday said the Oxygen Express train with 100 tonnes medical oxygen has left for Maharashtra from its plant in Visakhapatnam. First Oxygen Express chugged off RINL VizagSteelPlant site carrying 100 tons of Liquid Medical...

Pope Francis praises efforts in climate summit

Pope Francis is urging participants in the U.S.-hosted global climate summit to ensure that the post-pandemic world is cleaner, purer and preserved.Francis delivered a short video message Thursday to the summit, praising the initiative. He ...

Give Feedback